Bio Protech Inc. (XKON:199290)
South Korea · Delayed Price · Currency is KRW 383.00
+4.00 (1.06%)
At close: Jan 30, 2026
Bio Protech Revenue
In the year 2015, Bio Protech had annual revenue of 20.58B KRW with 10.59% growth.
Revenue
20.58B
Revenue Growth
+10.59%
P/S Ratio
0.27
Revenue / Employee
190.54M
Employees
108
Market Cap
5.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2015 | 20.58B | 1.97B | 10.59% |
| Dec 31, 2014 | 18.61B | 553.74M | 3.07% |
| Dec 31, 2013 | 18.05B | 47.69M | 0.26% |
| Dec 31, 2012 | 18.01B | 1.14B | 6.78% |
| Dec 31, 2011 | 16.86B | 365.98M | 2.22% |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 117.11B |
| Corentec | 106.14B |
| Sanigen Co. | 27.30B |
| Alpha AI | 25.98B |
| Finemedix | 10.48B |
| Genolution | 9.15B |
| Celemics | 6.13B |
| TASCOM | 5.53B |